A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients(SUPER-1)
Clinical trial NCT04994288 · COMPLETED
Trial details
- NCT number
- NCT04994288
- Sponsor
- Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-03
- Primary completion
- 2023-06-20
- Enrollment
- 547
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.